{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T19:19:22Z","timestamp":1758050362199,"version":"3.44.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,10]],"date-time":"2024-11-10T00:00:00Z","timestamp":1731196800000},"content-version":"am","delay-in-days":375,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National du Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.bulcan.2023.02.026","type":"journal-article","created":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T08:16:11Z","timestamp":1688717771000},"page":"1097-1105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Physiopathologie des syndromes my\u00e9lodysplasiques"],"prefix":"10.1016","volume":"110","author":[{"given":"Michaela","family":"Fontenay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismael","family":"Boussaid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Chapuis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bulcan.2023.02.026_bib0265","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/bjh.16206","article-title":"How we manage adults with myelodysplastic syndrome","volume":"189","author":"Fenaux","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0270","first-page":"1","article-title":"Molecular international prognostic scoring system for myelodysplastic syndromes","volume":"1","author":"Bernard","year":"2022","journal-title":"N Engl J Med Evidences"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0275","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1182\/blood-2011-12-399683","article-title":"Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterations","volume":"120","author":"Will","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0280","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.ccr.2014.03.036","article-title":"Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo","volume":"25","author":"Woll","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0285","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1182\/blood-2016-03-707745","article-title":"Architectural and functional heterogeneity of hematopoietic stem\/progenitor cells in non-del(5q) myelodysplastic syndromes","volume":"129","author":"Chesnais","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0290","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1182\/blood-2012-01-404699","article-title":"Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDS","volume":"120","author":"Barreyro","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0295","doi-asserted-by":"crossref","first-page":"eaaj2025","DOI":"10.1126\/scitranslmed.aaj2025","article-title":"CD99 is a therapeutic target on disease stem cells in myeloid malignancies","volume":"9","author":"Chung","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0300","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.stem.2010.11.014","article-title":"TIM-3 is a promising target to selectively kill acute myeloid leukemia stem cells","volume":"7","author":"Kikushige","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0305","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/nm0996-1011","article-title":"The aging of hematopoietic stem cells","volume":"2","author":"Morrison","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0310","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.1073\/pnas.1000834107","article-title":"Functionally distinct hematopoietic stem cells modulate hematopoietic lineage potential during aging by a mechanism of clonal expansion","volume":"107","author":"Beerman","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0315","doi-asserted-by":"crossref","first-page":"e41258","DOI":"10.7554\/eLife.41258","article-title":"Murine HSCs contribute actively to native hematopoiesis but with reduced differentiation capacity upon aging","volume":"7","author":"S\u00e4wen","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0320","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.stem.2014.03.002","article-title":"Epigenomic profiling of young and aged HSCs reveals concerted changes during aging that reinforce self-renewal","volume":"14","author":"Sun","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0325","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.stem.2016.08.003","article-title":"RNA splicing modulation selectively impairs leukemia stem cell maintenance in secondary human AML","volume":"19","author":"Crews","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0330","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1158\/2159-8290.CD-18-1474","article-title":"Aging human hematopoietic stem cells manifest profound epigenetic reprogramming of enhancers that may predispose to leukemia","volume":"9","author":"Adelman","year":"2019","journal-title":"Cancer Discov"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0335","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nature14131","article-title":"Exit from dormancy provokes DNA-damage-induced attrition in haematopoietic stem cells","volume":"520","author":"Walter","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0340","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nature13619","article-title":"Replication stress is a potent driver of functional decline in ageing haematopoietic stem cells","volume":"512","author":"Flach","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0345","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0350","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0355","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nature13038","article-title":"Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia","volume":"506","author":"Shlush","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0360","first-page":"1161","article-title":"Mutational spectrum and dynamics of clonal hematopoiesis in anemia of older individuals","volume":"135","author":"van Zeventer","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0365","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0370","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1056\/NEJMoa1106968","article-title":"Clonal architecture of secondary acute myeloid leukemia","volume":"366","author":"Walter","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0375","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41591-018-0267-4","article-title":"Myelodysplastic syndrome progression to acute myeloid leukemia at the stem cell level","volume":"25","author":"Chen","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0380","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1038\/s41591-020-1008-z","article-title":"Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes","volume":"26","author":"Bernard","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0385","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1182\/blood-2011-03-343475","article-title":"Defective nuclear localization of Hsp70 is associated with dyserythropoiesis and GATA-1 cleavage in myelodysplastic syndromes","volume":"119","author":"Frisan","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0390","doi-asserted-by":"crossref","first-page":"746","DOI":"10.3324\/haematol.2019.239970","article-title":"Integrated analyses of translatome and proteome identify the rules of translation selectivity in RPS14-deficient cells","volume":"106","author":"Boussaid","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0395","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/nm.4047","article-title":"Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9","volume":"22","author":"Schneider","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0400","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nm.2063","article-title":"A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q- syndrome","volume":"16","author":"Barlow","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0405","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nm.2054","article-title":"Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype","volume":"16","author":"Starczynowski","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0410","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1038\/s41375-018-0350-3","article-title":"Rps14, Csnk1a1 and miRNA145\/miRNA146a deficiency cooperate in the clinical phenotype and activation of the innate immune system in the 5q- syndrome","volume":"33","author":"Ribezzo","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0415","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1182\/blood-2018-04-843771","article-title":"Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes\/pathways and clinical associations","volume":"132","author":"Pellagatti","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0420","doi-asserted-by":"crossref","first-page":"eaav5467","DOI":"10.1126\/scitranslmed.aav5467","article-title":"A variant erythroferrone disrupts iron homeostasis in SF3B1-mutated myelodysplastic syndrome","volume":"11","author":"Bondu","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0425","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1101\/gr.181016.114","article-title":"U2AF1 mutations alter splice site recognition in hematological malignancies","volume":"25","author":"Ilagan","year":"2015","journal-title":"Genome Res"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0430","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ccell.2015.04.006","article-title":"SRSF2 mutations contribute to myelodysplasia by mutant-specific effects on exon recognition","volume":"27","author":"Kim","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0435","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.cell.2013.04.028","article-title":"SR proteins collaborate with 7SK and promoter-associated nascent RNA to release paused polymerase","volume":"153","author":"Ji","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0440","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.molcel.2017.12.029","article-title":"The augmented R-loop is a unifying mechanism for myelodysplastic syndromes induced by high-risk splicing factor mutations","volume":"69","author":"Chen","year":"2018","journal-title":"Mol Cell"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0445","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.3324\/haematol.2020.254193","article-title":"Replication stress signaling is a therapeutic target in myelodysplastic syndromes with splicing factor mutations","volume":"106","author":"Flach","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0450","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1158\/0008-5472.CAN-17-3970","article-title":"Spliceosome mutations induce R loop-associated sensitivity to ATR inhibition in myelodysplastic syndromes","volume":"78","author":"Nguyen","year":"2018","journal-title":"Cancer Res"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0455","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ccell.2016.08.006","article-title":"Physiologic expression of Sf3b1(K700E) causes impaired erythropoiesis, aberrant splicing, and sensitivity to therapeutic spliceosome modulation","volume":"30","author":"Obeng","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0460","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.stem.2022.05.006","article-title":"Clonal hematopoiesis: mutation-specific adaptation to environmental change","volume":"29","author":"Florez","year":"2022","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0465","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41586-019-1618-0","article-title":"Coordinated alterations in RNA splicing and epigenetic regulation drive leukaemogenesis","volume":"574","author":"Yoshimi","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0470","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1158\/2159-8290.CD-19-0982","article-title":"Combined cohesin-RUNX1 deficiency synergistically perturbs chromatin looping and causes myelodysplastic syndromes","volume":"10","author":"Ochi","year":"2020","journal-title":"Cancer Discov"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0475","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/j.celrep.2016.11.031","article-title":"Chronic infection depletes hematopoietic stem cells through stress-induced terminal differentiation","volume":"17","author":"Matatall","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0480","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.stem.2018.10.013","article-title":"Inhibition of inflammatory signaling in Tet2 mutant preleukemic cells mitigates stress-induced abnormalities and clonal hematopoiesis","volume":"23","author":"Cai","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0485","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.stem.2016.08.021","article-title":"Mesenchymal inflammation drives genotoxic stress in hematopoietic stem cells and predicts disease evolution in human pre-leukemia","volume":"19","author":"Zambetti","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0490","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.stem.2014.02.014","article-title":"Myelodysplastic cells in patients reprogram mesenchymal stromal cells to establish a transplantable stem cell niche disease unit","volume":"14","author":"Medyouf","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0495","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1172\/JCI67580","article-title":"Induction of myelodysplasia by myeloid-derived suppressor cells","volume":"123","author":"Chen","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0500","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1182\/blood-2007-01-067546","article-title":"CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS)","volume":"110","author":"Kordasti","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0505","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3324\/haematol.2020.268136","article-title":"Reduced frequencies and functional impairment of dendritic cell subsets and non-classical monocytes in myelodysplastic syndromes","volume":"107","author":"Van Leeuwen-Kerkhoff","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0510","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.4049\/jimmunol.1200602","article-title":"Expansion of effector memory regulatory T cells represents a novel prognostic factor in lower risk myelodysplastic syndrome","volume":"189","author":"Mailloux","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0515","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1038\/s41375-021-01353-8","article-title":"Genomic landscape of MDS\/CMML associated with systemic inflammatory and autoimmune disease","volume":"35","author":"Zhao","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.bulcan.2023.02.026_bib0260","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1038\/s41375-019-0397-9","article-title":"S100A9-induced overexpression of PD-1\/PD-L1 contributes to ineffective hematopoiesis in myelodysplastic syndromes","volume":"33","author":"Cheng","year":"2019","journal-title":"Leukemia"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455123002813?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455123002813?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T19:38:01Z","timestamp":1757792281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455123002813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":52,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0007455123002813"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2023.02.026","relation":{},"ISSN":["0007-4551"],"issn-type":[{"type":"print","value":"0007-4551"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Physiopathologie des syndromes my\u00e9lodysplasiques","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2023.02.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}